BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Statutory Instruments


You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Misuse of Drugs (Amendment No. 2) Regulations 2006 No. 1450
URL: http://www.bailii.org/uk/legis/num_reg/2006/20061450.html

[New search] [Help]



STATUTORY INSTRUMENTS


2006 No. 1450

DANGEROUS DRUGS, ENGLAND AND WALES

DANGEROUS DRUGS, SCOTLAND

The Misuse of Drugs (Amendment No. 2) Regulations 2006

  Made 27th May 2006 
  Laid before Parliament 9th June 2006 
  Coming into force in accordance with regulation 2

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971[1].

     In accordance with section 31(3) of that Act, he has consulted with the Advisory Council on the Misuse of Drugs.

Citation, interpretation, and extent
     1. —(1) These Regulations may be cited as the Misuse of Drugs (Amendment No. 2) Regulations 2006.

    (2) In these Regulations, "the 2001 Regulations" means the Misuse of Drugs Regulations 2001[
2].

    (3) These Regulations extend to England, Wales and Scotland.

Commencement
     2. —(1) Subject to paragraphs (2) and (3), these Regulations come into force on 7 July 2006.

    (2) Regulations 7(1) and 10 come into force on 1 January 2007.

    (3) Regulations 5 and 6(5) in so far as it inserts paragraphs (1C) and (1D) into regulation 16 of the 2001 Regulations come into force in Wales on 1 January 2007.

Amendment of the Misuse of Drugs Regulations 2001
    
3. The 2001 Regulations shall be amended in accordance with regulations 4 to 11.

    
4. In regulation 2(1)—

     5. —(1) In regulation 15(1)—

    (2) After regulation 15(1), insert—

     6. —(1) In regulation 16(1), before "A person" insert "Subject to paragraph (5),".

    (2) In regulation 16(1)(a), before "unless" insert "subject to paragraphs (1A) and (1C),".

    (3) In regulation 16(1)(d), (e), and 16(4)(a) for "date specified in the prescription" substitute "appropriate date".

    (4) In regulations 16(1)(e) and 16(4)(a), for "thirteen weeks" substitute "twenty-eight days".

    (5) After regulation 16(1), insert—

    (6) After regulation 16(4), insert—

     7. —(1) After Regulation 19(1)(b), insert—

    (2) After regulation 19(2), insert—

     8. In regulation 20(e), for "the purposes of", substitute "purposes related to".

    
9. After regulation 23(3), insert—

     10. In Schedule 6, add the following columns to the form under "Part II Entries to be made in case of supply"—

Person collecting Schedule 2 controlled drug (patient/patient's rep/healthcare professional), and if healthcare professional, name and address Was proof of identity requested of patient/patient's representative (Yes/No) Was proof of identity of person collecting provided (Yes/No)
                                
                                
                                

    
11. In Schedule 8, after paragraph (h), insert—

Transitional provisions
    
12. The amendments to the 2001 Regulations made by regulation 6(4) and (6) so far as it relates to the insertion of regulation 16(5) into the 2001 Regulations apply only to prescriptions issued on or after 7 July 2006.

    
13. In relation to prescriptions issued in Wales before 1 January 2007, regulation 16(1)(a) of the 2001 Regulations shall not apply to persons in England and Scotland in so far as it relates to the requirements for the prescription to be issued on a prescription form provided by a Primary Care Trust or equivalent body for the purposes of private prescribing and to specify the prescriber identification number of the person issuing it.


Vernon Coaker
Parliamentary Under Secretary of State

Home Office
27th May 2006



EXPLANATORY NOTE

(This note is not part of the Regulations)


These Regulations amend the Misuse of Drugs Regulations 2001 (S.I. 2001/3998) ("the 2001 Regulations").

Regulation 2 sets out the commencement arrangements for these Regulations.

Regulation 4 inserts a number of new definitions into regulation 2(1) of the 2001 Regulations.

Regulation 5 amends regulation 15 of the 2001 Regulations in respect of private prescriptions issued for human use containing controlled drugs specified in Schedules 1, 2 or 3 to the 2001 Regulations. These prescriptions must be written on a prescription form issued for the purposes of private prescribing by a Primary Care Trust in England, a Local Health Board in Wales or a Health Board in Scotland, and must specify the prescriber identification number of the person issuing it. An exception is, however, created where the issuer of the prescription believes on reasonable grounds that a private prescription is to be supplied by a pharmacist in a hospital: in that case the prescription does not need to be written on on a prescription form issued for the purposes of private prescribing by a Primary Care Trust in England, a Local Health Board in Wales or a Health Board in Scotland. "Prescriber identification number" and "private prescribing" are two of the new defined terms in the 2001 Regulations.

Regulation 6 amends regulation 16 of the 2001 Regulations. It changes the maximum validity period under regulation 16 of the 2001 Regulations for a prescription containing a controlled drug specified in Schedules 1 to 4 to the 2001 Regulations from 13 weeks to 28 days. This will mean that a controlled drug specified in Schedules 1 to 4 to the 2001 Regulations may not be supplied on a prescription (subject to regulation 16(4) of the 2001 Regulations) more than 28 days after the appropriate date as defined in new regulation 16(7) of the 2001 Regulations.

Regulation 6 also amends regulation 16 of the 2001 Regulations to provide exceptions to the requirement under regulation 16(1)(a) of the 2001 Regulations that a person shall not supply a drug specified in Schedules 1, 2 or 3 (except temazepam) to the 2001 Regulations on prescription unless the prescription complies with regulation 15 of the 2001 Regulations.

Regulation 6 also introduces provisions relating to the identification of persons collecting prescriptions for controlled drugs in Schedule 2 to the 2001. Regulations 7 and 10 make consequential changes to the recording requirements and Controlled Drugs Register respectively.

Regulations 8, 9 and 11 make minor amendments to the 2001 Regulations and regulations 12 and 13 contain transitional provisions.


Notes:

[1] 1971 c.38. Section 22 of that Act was amended by section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979 (c.2).back

[2] S.I. 2001/3998, to which there are a number of amendments, the relevant ones being made by S.I. 2003/1653, S.I. 2003/2429, S.I. 2004/1771, S.I. 2005/2864, S.I. 2005/271 and S.I. 2006/986.back

[3] 1978 c.29. Section 10 of that Act has been amended by paragraph 2(4) of Schedule 2 to the Smoking, Health and Social Care (Scotland) Act 2005 asp. 13.back

[4] 1977 c.49. Section 16BA of that Act was inserted by section 6(1) of the National Health Service Reform and Healthcare Professions Act 2002 (c.17).back

[5] S.I. 2005/2414.back

[6] S.I 1972/1265 (NI 14).back

[7] 1968 c.67. The definition of "pharmacist" is contained in section 132 of that Act, which was amended by S.I. 1976/1213.back

[8] Section 16A of that Act was inserted by section 2(1) of the Health Act 1999 (c.8).back

[9] S.I. 1997/1830; the definition of "registered occupational therapist" was inserted by S.I. 2004/1189.back

[10] S.I. 1997/1830; the definition of "registered orthotist and prosthetist" was inserted by S.I. 2004/1189.back

[11] 1977 c.49. The definition of "healthcare professional" is contained in section 28D(2) of that Act, which was inserted by section 21(1) of the National Health Service (Primary Care) Act 1997 (c.46) and amended by section 177(1), (4) of the Health and Social Care (Community Health and Standards) Act 2003 (c.43).back



ISBN 0 11 074641 4


 © Crown copyright 2006

Prepared 9 June 2006


BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/legis/num_reg/2006/20061450.html